AMPK, a central regulator of cellular metabolism, mediates phosphorylation of target substrates and plays a paramount role in the regulation and maintenance of energy homeostasis, which is emerging as one of the most promising targets in the prevention and treatment of obesity based on its pivotal role in physiology and pathology [29,30]. The gene discussed is PRKAA1; the disease is obesity disorder.